Notably, this strategy involving activated EGFR competing with F-actin for ACTN4 to disrupt the cytoskeleton is exploited not only by meningitic E. coli K1 and K2 strains, but also by meningitis-causing S. suis strains. The gene discussed is EGFR; the disease is infectious meningitis.